8-K filing — PetVivo Holdings, Inc. (PETV)
Filed: 2026-08-20 AccNo: 0001493152-26-039397 Size: 27 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
PetVivo Holdings Announces Peer-Reviewed Data Publication For Spryng Canine Osteoarthritis And Cranial Cruciate Ligament Disease Treatment
The prospective proof-of-concept study enrolled 40 client-owned dogs diagnosed with unilateral suspected cranial cruciate disease and osteoarthritis. Each dog received a single intra-articular injection of the
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 14, 2026, 12:05 PM
- Checked
- Jul 14, 2026, 12:05 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
PetVivo Holdings Q1 EPS $(0.05) Up From $(0.10) YoY, Sales $337.572K Up From $297.500K YoY
PetVivo Holdings (OTC:PETV) reported quarterly losses of $(0.05) per share. This is a 50 percent increase over losses of $(0.10) per share from the same period last year. The company reported $337.572 thousand in sales
Read original at benzingaPetVivo Reaches Settlement With VetStem, Terminates PrecisePRP License Agreement; PetVivo's Sole Remaining Financial Obligation Under The Settlement Agreement Is The Payment Of An Aggregate Of $75,000, Consisting Of Two Scheduled Cash Payments
PetVivo Holdings, Inc. (OTCQX:PETV, OTCID: PETVW))) working in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc., Cosmeta Corp and PetVivo AI, Inc. (collectively "PetVivo" or the
Read original at benzinga